Mouse VEGFR1/Flt-1 PE-conjugated Antibody

Catalog # Availability Size / Price Qty
FAB4711P
Detection of VEGF R1/Flt‑1 in bEnd.3 Mouse Cell Line by Flow Cytometry.
3 Images
Product Details
Citations (8)
FAQs
Supplemental Products
Reviews

Mouse VEGFR1/Flt-1 PE-conjugated Antibody Summary

Species Reactivity
Mouse
Specificity
Detects mouse VEGF R1/Flt‑1 in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human VEGF R1, recombinant mouse (rm) VEGF R2, or rmVEGF R3 is observed.
Source
Monoclonal Rat IgG2B Clone # 141522
Purification
Protein A or G purified from hybridoma culture supernatant
Immunogen
Mouse myeloma cell line NS0-derived recombinant mouse VEGF R1/Flt‑1
Ser27-Glu759
Accession # P35969
Formulation
Supplied in a saline solution containing BSA and Sodium Azide.
Label
Phycoerythrin (Excitation= 488 nm, Emission= 565-605 nm)

Applications

Recommended Concentration
Sample
Flow Cytometry
10 µL/106 cells
See below

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Scientific Data

Flow Cytometry Detection of VEGF R1/Flt-1 antibody in bEnd.3 Mouse Cell Line antibody by Flow Cytometry. View Larger

Detection of VEGF R1/Flt‑1 in bEnd.3 Mouse Cell Line by Flow Cytometry. bEnd.3 mouse endothelioma cell line was stained with Rat Anti-Mouse VEGF R1/Flt-1 PE-conjugated Monoclonal Antibody (Catalog # FAB4711P, filled histogram) or isotype control antibody (Catalog # IC013P, open histogram). View our protocol for Staining Membrane-associated Proteins.

Flow Cytometry Detection of Mouse VEGFR1/Flt-1 by Flow Cytometry View Larger

Detection of Mouse VEGFR1/Flt-1 by Flow Cytometry Fibroblast-derived VEGF enriches VEGFR1+ cells bone marrow and pre-metastatic sites.(a) Immunohistochemical expression of mouse VEGF in the tumour xenografts established with KYSE150-Id1, KYSE150-Id1-shIGF2 or vector control cells (scale bar, 20 μm). (b) Flow cytometry data showing the expression of VEGFR1+ cells in bone marrow (upper panel) and lungs (lower panel) of mice with subcutaneous implantation of indicated fibroblasts and treatment (female 6–8-week-old nude mice, n=3 per group). (c,d) Flow cytometry analysis of VEGFR1+ cells (c) and comparison of tumour volume (d) of subcutaneous tumour xenografts established from co-implantation of KYSE150 cells and indicated NEFs in the presence or absence of Avastin treatment. Photographs show representative tumours of the three groups (female 6–8-week-old nude mice, n=6 per group; scale bar, 1 cm). Bars, s.d.; *P<0.05; **P<0.01; ***P<0.001 by Student's t-test. Image collected and cropped by CiteAb from the following publication (https://www.nature.com/articles/ncomms14399), licensed under a CC-BY license. Not internally tested by R&D Systems.

Flow Cytometry Detection of Mouse VEGFR1/Flt-1 by Flow Cytometry View Larger

Detection of Mouse VEGFR1/Flt-1 by Flow Cytometry Fibroblast-derived VEGF enriches VEGFR1+ cells bone marrow and pre-metastatic sites.(a) Immunohistochemical expression of mouse VEGF in the tumour xenografts established with KYSE150-Id1, KYSE150-Id1-shIGF2 or vector control cells (scale bar, 20 μm). (b) Flow cytometry data showing the expression of VEGFR1+ cells in bone marrow (upper panel) and lungs (lower panel) of mice with subcutaneous implantation of indicated fibroblasts and treatment (female 6–8-week-old nude mice, n=3 per group). (c,d) Flow cytometry analysis of VEGFR1+ cells (c) and comparison of tumour volume (d) of subcutaneous tumour xenografts established from co-implantation of KYSE150 cells and indicated NEFs in the presence or absence of Avastin treatment. Photographs show representative tumours of the three groups (female 6–8-week-old nude mice, n=6 per group; scale bar, 1 cm). Bars, s.d.; *P<0.05; **P<0.01; ***P<0.001 by Student's t-test. Image collected and cropped by CiteAb from the following publication (https://www.nature.com/articles/ncomms14399), licensed under a CC-BY license. Not internally tested by R&D Systems.

Preparation and Storage

Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Protect from light. Do not freeze.
  • 12 months from date of receipt, 2 to 8 °C as supplied.

Background: VEGFR1/Flt-1

VEGF R1 is one of the five receptor tyrosine kinases (RTKs) (VEGF R1, KDR/Flk-1, Flt-4, Tie-1, and Tek/Tie-2) whose expression is almost exclusively restricted to the endothelial cells. Tie-1 and tek/tie-2 define a new class of RTKs containing two immunoglobulin-like domains, three EGF homology domains and three fibronectin type III domains in their extracellular regions. VEGF R1/Flt-1, VEGF R2/KDR/Flk-1, VEGF R3/Flt-4 are members of the class III subfamily of RTKs containing seven immunoglobulin-like repeats in their extracellular domains. All five RTKs are likely to play central roles in vasculogenesis and angiogenesis.

Full length mouse VEGF R1 mRNA encodes a 1333 amino acid (aa) residue precursor with a predicted 22 aa residue signal peptide. Mature VEGF R1 is composed of a 737 aa residue extracellular domain, a 22 aa residue transmembrane domain and a 552 aa residue cytoplasmic domain. As a result of alternative splicing of the mRNA, a cDNA encoding a truncated form of VEGF R1, lacking the seventh immunoglobulin-like domain, the transmembrane and intracellular domains, has been cloned. The recombinant soluble VEGF R1/Fc chimera binds VEGF and PlGF with high affinity and is a potent VEGF antagonist.

References
  1. He, Y. et al. (1999) Molecular Endocrinology 13:537.
  2. Ferrara, N. and T. Davis-Smyth (1997) Endocrine Reviews 8:4.
Long Name
Vascular Endothelial Growth Factor Receptor 1
Entrez Gene IDs
2321 (Human); 14254 (Mouse)
Alternate Names
EC 2.7.10; EC 2.7.10.1; FLT; FLT1; Flt-1; Fms-like tyrosine kinase 1; fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascularpermeability factor receptor); FRT; Tyrosine-protein kinase FRT; Tyrosine-protein kinase receptor FLT; vascular endothelial growth factor receptor 1; Vascular permeability factor receptor; VEGF R1; VEGFR1; VEGFR-1

Product Datasheets

You must select a language.

x

Citations for Mouse VEGFR1/Flt-1 PE-conjugated Antibody

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

8 Citations: Showing 1 - 8
Filter your results:

Filter by:

  1. Interaction between PD-L1 and soluble VEGFR1 in glioblastoma-educated macrophages
    Authors: X Liu, Z Li, J Sun, Z Zhang, W Li
    BMC Cancer, 2023-03-20;23(1):259.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  2. Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti-PD-1 immunotherapy
    Authors: Theivanthiran B, Yarla N, Haykal T et al.
    Science Translational Medicine
  3. Visualization of Proliferative Vascular Endothelial Cells in Tumors in�Vivo by Imaging Their Partner of Sld5-1 Promoter Activity
    Authors: D Yamakawa, W Jia, H Kidoya, S Hosojima, M Torigata, L Zhang, N Takakura
    Am. J. Pathol., 2018-04-09;0(0):.
    Species: Mouse
    Sample Types: Tissue Homogenates
    Applications: Flow Cytometry
  4. Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression
    Authors: WW Xu, B Li, XY Guan, SK Chung, Y Wang, YL Yip, SY Law, KT Chan, NP Lee, KW Chan, LY Xu, EM Li, SW Tsao, QY He, AL Cheung
    Nat Commun, 2017-02-10;8(0):14399.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  5. VEGFR1-positive macrophages facilitate liver repair and sinusoidal reconstruction after hepatic ischemia/reperfusion injury.
    Authors: Ohkubo, Hirotoki, Ito, Yoshiya, Minamino, Tsutomu, Eshima, Koji, Kojo, Ken, Okizaki, Shin-ich, Hirata, Mitsuhir, Shibuya, Masabumi, Watanabe, Masahiko, Majima, Masataka
    PLoS ONE, 2014-08-27;9(8):e105533.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  6. Dendritic cells: In vitro culture in two- and three-dimensional collagen systems and expression of collagen receptors in tumors and atherosclerotic microenvironments.
    Authors: Sprague L, Muccioli M, Pate M, Singh M, Xiong C, Ostermann A, Niese B, Li Y, Li Y, Courreges M, Benencia F
    Exp Cell Res, 2014-02-22;323(1):7-27.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  7. Expression of VEGF receptors on endothelial cells in mouse skeletal muscle.
    Authors: Imoukhuede, Princess, Popel, Aleksand
    PLoS ONE, 2012-09-12;7(9):e44791.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  8. Bone marrow subsets differentiate into endothelial cells and pericytes contributing to Ewing's tumor vessels.
    Authors: Reddy K, Zhou Z, Schadler K
    Mol. Cancer Res., 2008-06-01;6(6):929-36.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Flow Cytometry

FAQs

No product specific FAQs exist for this product, however you may

View all Antibody FAQs
Loading...

Reviews for Mouse VEGFR1/Flt-1 PE-conjugated Antibody

There are currently no reviews for this product. Be the first to review Mouse VEGFR1/Flt-1 PE-conjugated Antibody and earn rewards!

Have you used Mouse VEGFR1/Flt-1 PE-conjugated Antibody?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review